KOSDAQ · Healthcare · ₩1T
₩16,850-2.38%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.4% · as of 26.09.11
Among 34 바이오 peers
Quarterly Revenue Growth
“이번 분기는 새 치료제 개발 진전이 핵심이에요.”
In the company's words · 2026 2분기 filing